203 related articles for article (PubMed ID: 2107558)
1. 5-HT1C receptors in the serotonergic control of periaqueductal gray induced aversion in rats.
Jenck F; Broekkamp CL; Van Delft AM
Psychopharmacology (Berl); 1990; 100(3):372-6. PubMed ID: 2107558
[TBL] [Abstract][Full Text] [Related]
2. Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors.
Kennett GA; Curzon G
Br J Pharmacol; 1988 May; 94(1):137-47. PubMed ID: 3401632
[TBL] [Abstract][Full Text] [Related]
3. Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors.
Kennett GA; Curzon G
Psychopharmacology (Berl); 1988; 96(1):93-100. PubMed ID: 2906446
[TBL] [Abstract][Full Text] [Related]
4. Effects of the 5-HT1C/5-5-HT2 receptor agonists DOI and alpha-methyl-5-HT on plasma glucose and insulin levels in the rat.
Chaouloff F; Laude D; Baudrie V
Eur J Pharmacol; 1990 Oct; 187(3):435-43. PubMed ID: 2127400
[TBL] [Abstract][Full Text] [Related]
5. Involvement of 5-HT1C-receptors in drug-induced penile erections in rats.
Berendsen HH; Jenck F; Broekkamp CL
Psychopharmacology (Berl); 1990; 101(1):57-61. PubMed ID: 2343074
[TBL] [Abstract][Full Text] [Related]
6. Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists.
Kennett GA; Whitton P; Shah K; Curzon G
Eur J Pharmacol; 1989 May; 164(3):445-54. PubMed ID: 2767117
[TBL] [Abstract][Full Text] [Related]
7. Opposite control mediated by central 5-HT1A and non-5-HT1A (5-HT1B or 5-HT1C) receptors on periaqueductal gray aversion.
Jenck F; Broekkamp CL; Van Delft AM
Eur J Pharmacol; 1989 Feb; 161(2-3):219-21. PubMed ID: 2524392
[TBL] [Abstract][Full Text] [Related]
8. Receptor subtypes mediating facilitation by serotonin of excitability of spinal motoneurons.
Jackson DA; White SR
Neuropharmacology; 1990 Sep; 29(9):787-97. PubMed ID: 2149874
[TBL] [Abstract][Full Text] [Related]
9. Anorexia induced by M-trifluoromethylphenylpiperazine (TFMPP) in rats.
Kłodzińska A; Chojnacka-Wójcik E
Pol J Pharmacol Pharm; 1990; 42(1):13-7. PubMed ID: 2281017
[TBL] [Abstract][Full Text] [Related]
10. Effects of various serotonin receptor subtype-selective antagonists alone and on m-chlorophenylpiperazine-induced neuroendocrine changes in rats.
Aulakh CS; Hill JL; Murphy DL
J Pharmacol Exp Ther; 1992 Nov; 263(2):588-95. PubMed ID: 1432690
[TBL] [Abstract][Full Text] [Related]
11. Behavioural evidence for functional interactions between 5-HT-receptor subtypes in rats and mice.
Berendsen HH; Broekkamp CL
Br J Pharmacol; 1990 Nov; 101(3):667-73. PubMed ID: 2150180
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonists.
Bagdy G; Sved AF; Murphy DL; Szemeredi K
Eur J Pharmacol; 1992 Jan; 210(3):285-9. PubMed ID: 1535317
[TBL] [Abstract][Full Text] [Related]
13. Modulation of brainstem 5-HT1C receptors by serotonergic drugs in the rat.
Pranzatelli MR; Tailor PT
Gen Pharmacol; 1994 Oct; 25(6):1279-84. PubMed ID: 7875557
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of 5-HT1A and 5-HT2 but not 5-HT1C receptor mediated behaviour in rats following chronic treatment with 5-HT receptor agonists, antagonists or anti-depressants.
Berendsen HH; Broekkamp CL
Psychopharmacology (Berl); 1991; 105(2):219-24. PubMed ID: 1839064
[TBL] [Abstract][Full Text] [Related]
15. Vascular and cardiac effects of alpha-methyl-5-HT and DOI are mediated by different 5-HT receptors in the pithed rat.
Chaouche-Teyara K; Fournier B; Safar M; Dabiré H
Eur J Pharmacol; 1993 Nov; 250(1):67-75. PubMed ID: 7907025
[TBL] [Abstract][Full Text] [Related]
16. 5-HT2 receptor activation in the midbrain periaqueductal grey (PAG) reduces anxiety-like behaviour in mice.
Nunes-de-Souza V; Nunes-de-Souza RL; Rodgers RJ; Canto-de-Souza A
Behav Brain Res; 2008 Feb; 187(1):72-9. PubMed ID: 17935799
[TBL] [Abstract][Full Text] [Related]
17. Neurons in the hypothalamic paraventricular nucleus mediate the serotonergic stimulation of prolactin secretion via 5-HT1c/2 receptors.
Rittenhouse PA; Levy AD; Li Q; Bethea CL; Van de Kar LD
Endocrinology; 1993 Aug; 133(2):661-7. PubMed ID: 8344205
[TBL] [Abstract][Full Text] [Related]
18. Novel regulation of 5-HT1C receptors: down-regulation induced both by 5-HT1C/2 receptor agonists and antagonists.
Pranzatelli MR; Murthy JN; Tailor PT
Eur J Pharmacol; 1993 Jan; 244(1):1-5. PubMed ID: 8420788
[TBL] [Abstract][Full Text] [Related]
19. Serotonin (5-HT2) receptor mediated enhancement of cortical unit activity.
Neuman RS; Zebrowska G
Can J Physiol Pharmacol; 1992 Dec; 70(12):1604-9. PubMed ID: 1301238
[TBL] [Abstract][Full Text] [Related]
20. Role of 5-HT receptor subtypes in the modulation of dorsal periaqueductal gray generated aversion.
Nogueira RL; Graeff FG
Pharmacol Biochem Behav; 1995 Sep; 52(1):1-6. PubMed ID: 7501649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]